The University of Chicago Header Logo

Connection

Mark Kozloff to RNA, Messenger

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about RNA, Messenger.
Mark Kozloff
Connection Strength
0.019
RNA, Messenger
  1. Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.